Skip to content

uniQure QURE Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
BridgeBio Pharma logo
BridgeBio PharmaBBIO
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's deferred tax assets and other non-current assets?
uniQure (QURE) reported deferred tax assets and other non-current assets of $5.54M in Q1 2026.
How has uniQure's deferred tax assets and other non-current assets changed year-over-year?
uniQure's deferred tax assets and other non-current assets increased by 2.1% year-over-year, from $5.43M to $5.54M.
What is the long-term trend for uniQure's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), uniQure's deferred tax assets and other non-current assets has grown at a 15.1% compound annual growth rate (CAGR), from $2.75M to $5.56M.